Status:
UNKNOWN
Digital Marking Systems
Lead Sponsor:
Vienna Institute for Research in Ocular Surgery
Conditions:
Cataract
Eligibility:
All Genders
21-105 years
Phase:
NA
Brief Summary
Comparison of the alignment axis of the Alcon Verion and the Zeiss Callisto alignment systems intraoperatively
Detailed Description
In most patients undergoing cataract surgery, emmetropia can be achieved by implantation of a monofocal intraocular lens (IOL). However, several studies have shown that approximately 20% to 30% of pat...
Eligibility Criteria
Inclusion
- age-related cataract and scheduled for cataract surgery
- age 21 or older
- written informed consent prior to surgery
Exclusion
- dense cataract or corneal pathology that would significantly influence the measurements
- previous ocular surgery, ocular inflammation, or ocular trauma
- nystagmus or pathologies that might affect patient's fixation
- pregnancy
- corneal astigmatism \> 1.5 dpt. or need for a toric IOL
Key Trial Info
Start Date :
July 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2024
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT05220683
Start Date
July 1 2021
End Date
July 1 2024
Last Update
February 2 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Vienna Institute for Research in Ocular Surgery (VIROS), Hanusch Hospital
Vienna, Austria, 1140